Intestinal T-Cell Lymphoma — Trials

Intestinal T-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

29 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04480788	CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study	unknown	Phase 1	9	PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY	1	Jan 6, 2021	clinicaltrials
NCT02533700	CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL	unknown	Phase 2	106	Shandong Provincial HospitalOTHER_GOV	1	Mar 10, 2020